嗜麦芽窄食单胞菌
医学
肺炎克雷伯菌
鲍曼不动杆菌
内科学
移植
多重耐药
肺移植
支气管肺泡灌洗
铜绿假单胞菌
微生物学
人口
抗药性
肺
细菌
生物
大肠杆菌
遗传学
基因
环境卫生
生物化学
作者
Rayid Abdulqawi,Rana Saleh,Reem Alameer,Haifa Aldakhil,Khaled Alkattan,Reem S. Almaghrabi,Sahar Althawadi,Mahmoud Hashim,Waleed Saleh,Amani Yamani,Eid Al Mutairy
标识
DOI:10.1016/j.jinf.2023.12.013
摘要
RationaleRespiratory culture screening is mandatory for all potential lung transplant donors. There is limited evidence on the significance of donor multidrug-resistant (MDR) bacteria on transplant outcomes. Establishing the safety of allografts colonized with MDR bacteria has implications for widening an already limited donor pool.ObjectivesWe aimed to describe the prevalence of respiratory MDR bacteria among our donor population and to test for associations with posttransplant outcomes.MethodsThis retrospective observational study included all adult patients who underwent lung-only transplantation for the first time at King Faisal Specialist Hospital & Research Centre in Riyadh from January 2015 through May 2022. The study evaluated donor bronchoalveolar lavage and bronchial swab cultures.Main resultsSixty-seven of 181 donors (37%) had respiratory MDR bacteria, most commonly MDR Acinetobacter baumannii (n=24), methicillin-resistant Staphylococcus aureus (n=18), MDR Klebsiella pneumoniae (n=8), MDR Pseudomonas aeruginosa (n=7), and Stenotrophomonas maltophilia (n=6).Donor respiratory MDR bacteria were not significantly associated with allograft survival or chronic lung allograft dysfunction (CLAD) in adjusted hazard models. Sensitivity analyses revealed an increased risk for 90-day mortality among recipients of allografts with MDR Klebsiella pneumoniae (n=6 with strains resistant to a carbapenem and n=2 resistant to a third-generation cephalosporin only) compared to those receiving culture-negative allografts (25.0% versus 11.1%, p=0.04). MDR Klebsiella pneumoniae (aHR 3.31, 95%CI 0.95-11.56) and Stenotrophomonas maltophilia (aHR 5.35, 95%CI 1.26-22.77) were associated with an increased risk for CLAD compared to negative cultures.ConclusionOur data suggest the potential safety of using lung allografts with MDR bacteria in the setting of appropriate prophylaxis; however, caution should be exercised in the case of MDR Klebsiella pneumoniae.
科研通智能强力驱动
Strongly Powered by AbleSci AI